Human Angiogenesis Antibody Array - Membrane (43 Targets) (ab193655)
Overview
-
Product name
Human Angiogenesis Antibody Array - Membrane (43 Targets)
See all Angiogenesis Antibody Array antibody arrays -
Sample type
Serum, Plasma, Other biological fluids, Cell Lysate, Cell culture media, Tissue Lysate -
Assay type
Semi-quantitative -
Species reactivity
Reacts with: Human -
Product overview
ab193655 can be used for simultaneous detection of 43 Human Angiogenesis proteins in serum, plasma, cell culture media and other liquid sample types. It comes as 1 kit including 2 separate membranes labelled C1 and C2 (see below for images showing the array layout on each membrane).
Targets: Angiogenin, Angiopoietin-1, Angiopoietin-2, Angiostatin, bFGF, EGF, ENA-78 (CXCL5), Endostatin, GCSF, GM-CSF, GRO alpha, GRO beta, GRO gamma, I-309 (TCA-3/CCL1), IFN-gamma, IGF-1, IL-10, IL-1 alpha (IL-1 F1), IL-1 beta (IL-1 F2), IL-2, IL-4, IL-6, IL-8 (CXCL8), I-TAC (CXCL11), Leptin, MCP-1 (CCL2), MCP-3 (MARC/CCL7), MCP-4 (CCL13), MMP-1, MMP-9, PDGF-BB, PECAM-1 (CD31), PLGF, RANTES (CCL5), TGF beta 1, Thrombopoietin (TPO), Tie-2,TIMP-1, TIMP-2, TNF alpha, uPAR, VEGF-A, VEGFR2, VEGFR3, VEGF-D.
-
Notes
If you are interested in this cytokine array, arrays ab133998, ab133997, ab134000, ab169808 and ab169804 may also be of interest. A list of human antibody membrane arrays is available here.
Abcam has not and does not intend to apply for the REACH Authorisation of customers’ uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses. -
Tested applications
Suitable for: Multiplex Protein Detectionmore details
Properties
-
Storage instructions
Store at -20°C. Please refer to protocols. -
Components 1 x 8 Membranes 1 x 4 Membranes 1,000X HRP-Conjugated Streptavidin 2 x 50µl 1 x 50µl 1X Blocking Buffer 4 x 25ml 2 x 25ml 20X Wash Buffer I 2 x 20ml 1 x 20ml 20X Wash Buffer II 2 x 20ml 1 x 20ml 2X Cell Lysis Buffer 2 x 16ml 1 x 16ml 8-Well Incubation Tray (with Lid) 2 units 1 unit Biotinylated Antibody Cocktail (C1) 4 vials 2 vials Biotinylated Antibody Cocktail (C2) 4 vials 2 vials Detection Buffer C 2 x 2.5ml 1 x 2.5ml Detection Buffer D 2 x 2.5ml 1 x 2.5ml Human Angiogenesis Antibody Array Membranes (C1) 1 x 8 units 1 x 4 units Human Angiogenesis Antibody Array Membranes (C2) 1 x 8 units 1 x 4 units -
Research areas
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab193655 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
Multiplex Protein Detection |
Use at an assay dependent concentration.
|
Notes |
---|
Multiplex Protein Detection
Use at an assay dependent concentration. |
Images
Datasheets and documents
-
SDS download
-
Datasheet download
References (8)
ab193655 has been referenced in 8 publications.
- Jadhao M et al. Endoglin Modulates TGFβR2 Induced VEGF and Proinflammatory Cytokine Axis Mediated Angiogenesis in Prolonged DEHP-Exposed Breast Cancer Cells. Biomedicines 10:N/A (2022). PubMed: 35203627
- Seo SH et al. Hypoxia-induced ELF3 promotes tumor angiogenesis through IGF1/IGF1R. EMBO Rep 23:e52977 (2022). PubMed: 35695065
- Danoy M et al. Investigation of the hepatic development in the coculture of hiPSCs-derived LSECs and HLCs in a fluidic microenvironment. APL Bioeng 5:026104 (2021). PubMed: 34027283
- Danoy M et al. Multi-omics analysis of hiPSCs-derived HLCs matured on-chip revealed patterns typical of liver regeneration. Biotechnol Bioeng 118:3716-3732 (2021). PubMed: 33404112
- Low SYY et al. Cerebrospinal fluid cytokines in metastatic group 3 and 4 medulloblastoma. BMC Cancer 20:554 (2020). PubMed: 32539808
- Shih HJ et al. IGFBP3 inhibits angiogenesis through intracellular regulation of THBS1 expression. Am J Cancer Res 10:1728-1744 (2020). PubMed: 32642286
- Hee E et al. Neuroblastoma patient-derived cultures are enriched for a mesenchymal gene signature and reflect individual drug response. Cancer Sci 111:3780-3792 (2020). PubMed: 32777141
- Maiti A et al. Class I histone deacetylase inhibitor suppresses vasculogenic mimicry by enhancing the expression of tumor suppressor and anti-angiogenesis genes in aggressive human TNBC cells. Int J Oncol 55:116-130 (2019). PubMed: 31059004